AUPH
Aurinia Pharmaceuticals Inc.
NASDAQ · CAHealthcareBiotechnology
$15.25-4.45%
Price as of Jul 20, 2026
AUPH capital
Aurinia Pharmaceuticals Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.12x
- Net debt / equity
- 0.05x
- Debt / assets
- 0.09x
- Debt / EBITDA
- 0.42x
- Net debt / EBITDA
- 0.17x
Liquidity & coverage
- Current ratio
- 5.55x
- Quick ratio
- 5.01x
- Cash ratio
- 4.38x
- Interest coverage
- 14.40x
- EBITDA / interest
- 18.72x
- Working capital
- $393.7M
Cash & dividend
- FCF / debt
- 2.41x
- Cash flow / debt
- 2.42x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.